Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2010

May 21, 2010

30870_dirs_2010-05-21_994bb4e5-4005-40ad-a4ad-660f8c0c81e5.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2010-05-20

Reporting Person: HEIDRICH A GRANT III (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-05-20 Stock Option (right to buy) $2.81 A 20000 Acquired 2020-05-20 Common Stock (20000) Direct

Footnotes

F1: The option shall vest and become exercisable in equal monthly installments such that the option shall be 100% vested on May 20, 2011.